Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Boston Scientific (NY:BSX)

95.20 +1.62 (+1.74%)
Streaming Delayed Price Updated: 12:04 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Shockwave Tumbles As Boston Scientific Takeover Talk Reportedly Breaks Down
An analyst says Shockwave would fit into Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $3,800 Today
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Boston Scientific: Here's What You Need To Know
Via Benzinga
Boston Scientific Approaches A Profit-Taking Zone On First-Quarter Beat
The company expects full-year organic sales growth of 8%. 
Via Investor's Business Daily
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Meta Platforms To Rally Around 67%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for Old Dominion Freight Line, Inc. (NASDAQ: ODFL) from $339 to $334. Morgan Stanley analyst Ravi Shanker maintained an Equal-Weight rating. Old Dominion shares fell... 
Via Benzinga
Boston Scientific Clocks Strong Q1 Earnings As Elective Surgeries Recover, Boosts FY23 Outlook
Boston Scientific Corp (NYSE: BSX) generated Q1 revenues 
Via Benzinga
Nasdaq Futures Surge On Microsoft, Alphabet Earnings Cheer: Analyst Tells Why Investors Might Not 'Sell In May And Go Away'
Stocks could rebound from Tuesday’s steep sell-off, as earnings from Alphabet, Inc. 
Via Benzinga
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday
The compay might soon be swallowed by a larger rival. 
Via The Motley Fool
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
8 Analysts Have This to Say About Boston Scientific
Via Benzinga
Shockwave Rockets As Boston Scientific Reportedly Mulls A Takeover
The deal would help bolster Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
NVIDIA, Boston Scientific And This Technology Stock Insiders Are Selling
The Nasdaq Composite closed higher by over 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Why Boston Scientific Shares Are Trading Higher Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Preview Of Boston Scientific's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
Thermo Fisher provided a bullish outlook, while Boston Scientific's profit view was short. 
Via Investor's Business Daily
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem. 
Via Benzinga
How Doug Godshall Ignited The Spark At Shockwave
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
The tech space is still bursting with opportunities for long-term investors. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.